Vernooij Meike W, Haag Mendel D M, van der Lugt Aad, Hofman Albert, Krestin Gabriel P, Stricker Bruno H, Breteler Monique M B
Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Arch Neurol. 2009 Jun;66(6):714-20. doi: 10.1001/archneurol.2009.42. Epub 2009 Apr 13.
Cerebral microbleeds are hemosiderin deposits in the brain that are indicative of microangiopathy. Microbleeds in strictly lobar brain locations have been related to cerebral amyloid angiopathy, a bleeding-prone disease state.
To investigate the relation between antithrombotic drug use and the presence of cerebral microbleeds, especially those in strictly lobar locations.
A population-based, cross-sectional analysis that used magnetic resonance imaging (MRI) to assess the presence and location of microbleeds. Complete information on outpatient use of platelet aggregation inhibitors and anticoagulant drugs before MRI was obtained from automated pharmacy records.
The Rotterdam Scan Study, a population-based imaging study in a general elderly community in the Netherlands.
A population-based sample of 1062 persons from a longitudinal cohort, 60 years and older, free of dementia, who underwent MRI examinations between August 15, 2005, and November 22, 2006.
Presence of cerebral microbleeds on MRI.
Compared with nonusers of antithrombotic drugs, cerebral microbleeds were more prevalent among users of platelet aggregation inhibitors (adjusted odds ratio [OR], 1.71; 95% confidence interval [CI], 1.21-2.41). We did not find a significant association for anticoagulant drugs and microbleed presence (OR, 1.49; 95% CI, 0.82-2.71). Strictly lobar microbleeds were more prevalent among aspirin users (adjusted OR compared with nonusers, 2.70; 95% CI, 1.45-5.04) than among persons using carbasalate calcium (adjusted OR, 1.16; 95% CI, 0.66-2.02). This difference was even more pronounced when comparing persons who had used similar dosages of both drugs.
This cross-sectional study shows that use of platelet aggregation inhibitors is related to the presence of cerebral microbleeds. Furthermore, aspirin and carbasalate calcium use may differently relate to the presence of strictly lobar microbleeds.
脑微出血是大脑中的含铁血黄素沉积,提示微血管病变。严格局限于脑叶部位的微出血与脑淀粉样血管病有关,这是一种易出血的疾病状态。
研究抗血栓药物的使用与脑微出血的存在之间的关系,尤其是严格局限于脑叶部位的微出血。
一项基于人群的横断面分析,使用磁共振成像(MRI)评估微出血的存在和位置。通过自动药房记录获取MRI检查前门诊使用血小板聚集抑制剂和抗凝药物的完整信息。
鹿特丹扫描研究,一项在荷兰普通老年社区进行的基于人群的影像学研究。
从一个纵向队列中抽取的1062名60岁及以上、无痴呆的人群样本,他们在2005年8月15日至2006年11月22日期间接受了MRI检查。
MRI上脑微出血的存在情况。
与未使用抗血栓药物的人相比,血小板聚集抑制剂使用者中脑微出血更为普遍(调整后的优势比[OR],1.71;95%置信区间[CI],1.21 - 2.41)。我们未发现抗凝药物与微出血存在之间有显著关联(OR,1.49;95%CI,0.82 - 2.71)。严格局限于脑叶的微出血在阿司匹林使用者中比使用卡巴匹林钙的人更普遍(与未使用者相比调整后的OR,2.70;95%CI,1.45 - 5.04)。当比较使用两种药物相似剂量的人群时,这种差异更加明显。
这项横断面研究表明,血小板聚集抑制剂的使用与脑微出血的存在有关。此外,阿司匹林和卡巴匹林钙的使用与严格局限于脑叶的微出血的存在可能有不同的关系。